Microsaic Systems plc Update on Publication of Interim Results

RNS Number : 0505L

Microsaic Systems plc

05 November 2024

 

5 November 2024

Microsaic Systems plc

 

("Microsaic" or the "Company")

 

Update on Publication of Interim Results

 

Further to the announcement of its FY23 financial results on 11 October 2024, Microsaic Systems plc (AIM: MSYS), an international developer and provider of testing solutions for unique and underserved public health and environmental markets, announces its interim financial results for the period ended 30 June 2024 ("H124") are now expected to be released in the first half of November.

 

 

Microsaic Systems plc Bob Moore, Acting Executive Chairman	[phone] via TPI
Singer Capital Markets (Nominated Adviser) Alex Bond / Oliver Platts	[phone]
Turner Pope Investments (TPI) Limited (Broker) Andy Thacker / James Pope	[phone]

 

About Microsaic Systems Group

 

Microsaic is highly experienced in the development, manufacture and supply of microelectronics instrumentation for markets requiring analytical testing in public and environmental health markets. The Company has recently acquired and integrated the assets of Modern Water with Microsaic Systems' technologies resulting in comprehensive water testing and other toxic testing capabilities.

Microsaic's products and solutions are commercially available through global markets via a network of regional and country specific distributors and partners.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NORKZMGMKKFGDZM